Section
People
Executive moves at pharma, PBM, payer, and GPO organizations
PeopleBriefing
Astellas trims stem cell research, GSK accelerates its ADC program, Daiichi exits OTC, Takeda ends mRNA pact, …
PeopleFiercePharma ↗
AI heavyweight Anthropic has appointed Novartis CEO Vas Narasimhan to its board of directors as the link betwe…
PeopleSTAT News ↗
Schwartz's background as a physician with plenty of government service experience will likely be popular among…
← Newer
Page 4
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.